【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 11
2 Introduction 12
2.1 Airway and Anesthesia Devices Overview 12
3 Products under Development 15
3.1 Airway and Anesthesia Devices – Pipeline Products by Stage of Development 15
3.2 Airway and Anesthesia Devices – Pipeline Products by Segment 16
3.3 Airway and Anesthesia Devices – Pipeline Products by Territory 17
3.4 Airway and Anesthesia Devices – Pipeline Products by Regulatory Path 18
3.5 Airway and Anesthesia Devices – Pipeline Products by Estimated Approval Date 19
3.6 Airway and Anesthesia Devices – Ongoing Clinical Trials 20
4 Airway and Anesthesia Devices – Pipeline Products under Development by Companies 21
4.1 Airway and Anesthesia Devices Companies – Pipeline Products by Stage of Development 21
4.2 Airway and Anesthesia Devices – Pipeline Products by Stage of Development 24
5 Airway and Anesthesia Devices Companies and Product Overview 27
5.1 Actuated Medical, Inc. Company Overview 27
5.1.1 Actuated Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Adroit USA, Inc Company Overview 29
5.2.1 Adroit USA, Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.3 Aerin Medical, Inc. Company Overview 30
5.3.1 Aerin Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Ambu A/S Company Overview 31
5.4.1 Ambu A/S Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Baylor College of Medicine Company Overview 35
5.5.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Biovo Technologies Ltd Company Overview 37
5.6.1 Biovo Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
5.7 Brio Device, LLC Company Overview 41
5.7.1 Brio Device, LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.8 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 42
5.8.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 CHESTMASTER Inc. Company Overview 43
5.9.1 CHESTMASTER Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Children’s Hospital Boston Company Overview 44
5.10.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 44
5.11 Chinese University of Hong Kong Company Overview 46
5.11.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 46
5.12 Cortical Dynamics Limited Company Overview 47
5.12.1 Cortical Dynamics Limited Pipeline Products & Ongoing Clinical Trials Overview 47
5.13 Drexel University Company Overview 48
5.13.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 48
5.14 ElectroCore, LLC Company Overview 49
5.14.1 ElectroCore, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.15 Enox Biopharma, Inc Company Overview 50
5.15.1 Enox Biopharma, Inc Pipeline Products & Ongoing Clinical Trials Overview 50
5.16 Fogless International AB Company Overview 51
5.16.1 Fogless International AB Pipeline Products & Ongoing Clinical Trials Overview 51
5.17 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 52
5.17.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.18 Hannover Medical School Company Overview 53
5.18.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 53
5.19 Hebrew University of Jerusalem Company Overview 55
5.19.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 55
5.20 Illumitube Company Overview 56
5.20.1 Illumitube Pipeline Products & Ongoing Clinical Trials Overview 56
5.21 Inscope Medical Solutions, LLC Company Overview 57
5.21.1 Inscope Medical Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 57
5.22 Intumed Ltd. Company Overview 58
5.22.1 Intumed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 58
5.23 Janus Development Group, Inc Company Overview 59
5.23.1 Janus Development Group, Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.24 Koronis Biomedical Technologies Corporation Company Overview 60
5.24.1 Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 60
5.25 Lazarus Medical, LLC Company Overview 61
5.25.1 Lazarus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 61
5.26 Liberate Medical, LLC Company Overview 62
5.26.1 Liberate Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.27 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 63
5.27.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 63
5.28 Materialise NV Company Overview 64
5.28.1 Materialise NV Pipeline Products & Ongoing Clinical Trials Overview 64
5.29 Medical Device Investments, Inc. Company Overview 66
5.29.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.30 Miach Medical Innovations Company Overview 69
5.30.1 Miach Medical Innovations Pipeline Products & Ongoing Clinical Trials Overview 69
5.31 Nevap, Inc Company Overview 70
5.31.1 Nevap, Inc Pipeline Products & Ongoing Clinical Trials Overview 70
5.32 Novo Path Medical Company Overview 71
5.32.1 Novo Path Medical Pipeline Products & Ongoing Clinical Trials Overview 71
5.33 Oculus Innovative Sciences, Inc. Company Overview 72
5.33.1 Oculus Innovative Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.34 PediaWorks LLC Company Overview 74
5.34.1 PediaWorks LLC Pipeline Products & Ongoing Clinical Trials Overview 74
5.35 PneumoSonics Inc. Company Overview 75
5.35.1 PneumoSonics Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.36 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 77
5.36.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 77
5.37 Rutgers, The State University of New Jersey Company Overview 78
5.37.1 Rutgers, The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 78
5.38 Sanovas, Inc. Company Overview 79
5.38.1 Sanovas, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.39 Sharklet Technologies, Inc. Company Overview 81
5.39.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.40 SonarMed, Inc. Company Overview 83
5.40.1 SonarMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.41 South African Medical Research Council Company Overview 85
5.41.1 South African Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 85
5.42 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 86
5.42.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 86
5.43 Teleflex Incorporated Company Overview 87
5.43.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 87
5.44 The Johns Hopkins University Company Overview 93
5.44.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 93
5.45 TrusTECH Company Overview 95
5.45.1 TrusTECH Pipeline Products & Ongoing Clinical Trials Overview 95
5.46 Tufts University Company Overview 96
5.46.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 96
5.47 University of Colorado Company Overview 97
5.47.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 97
5.48 University of Florida Company Overview 98
5.48.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 98
5.49 University of Michigan Pediatric Device Consortium Company Overview 99
5.49.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 99
5.50 University of Minnesota Company Overview 104
5.50.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 104
5.51 University of New Mexico Company Overview 105
5.51.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 105
5.52 University of Texas Health Science Center at Houston Company Overview 106
5.52.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 106
5.53 Vanderbilt University Company Overview 107
5.53.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 107
5.54 Vrije Universiteit Brussel Company Overview 108
5.54.1 Vrije Universiteit Brussel Pipeline Products & Ongoing Clinical Trials Overview 108
5.55 Xhale, Inc. Company Overview 109
5.55.1 Xhale, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
6 Airway and Anesthesia Devices- Recent Developments 110
7 Appendix 178
7.1 Methodology 178
7.2 About GlobalData 180
7.3 Contact Us 181
7.4 Disclaimer 181
【レポート販売概要】
■ タイトル：世界の気道装置・麻酔装置開発動向：医療機器パイプライン分析2015■ 英文：Airway and Anesthesia Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0136EPD
■ 調査対象地域：グローバル
- シラミ症(アタマジラミ寄生症)(Pediculosis (Head Lice Infestation))：世界の治験レビュー（2015年上半期版）Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015" provides data on the Pediculosis (Head Lice Infestation) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pediculosis (Head Lice Infestatio …
- CNOOC Limited：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013CNOOC Limited Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary CNOOC Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operati …
- ジュースの世界市場：ジュース飲料、ピュア・ジュース、ネクターAbout Juice Juice is a beverage extracted from fruits, vegetables, or a blend of both. It is a popular choice of drink worldwide because of its nutritional content and refreshing properties. Juices are divided into different categories according to their content, sales category, and origin. Though pure juice is rich in minerals, vitamins, and antioxidants, it lacks the fiber content present in the …
- 先端巨大症/巨人症治療薬の世界市場機会分析OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018 Summary GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM covered in this report. The market will grow moderately at a CAGR of 3.74% during the five year forecast period, generating sales of approximately $707m at the end of 2018. Growing at a CAGR of 4.58% …
- バラスト水処理の世界市場予測（～2022年）：物理的消毒法、機械的方法、化学的方法The ballast water treatment (BWT) market was valued at USD 14.29 Billion in 2016 and is expected to reach USD 118.77 Billion by 2022, at a CAGR of 37.19% during the forecast period. The growth of this market is propelled by the increasing government rules and regulations for the installation of BWT systems in the ships. The report covers the BWT market on the basis of technology, capacity, service …
- ヘアシャンプーの世界市場：健康シャンプー、フケ予防シャンプー、ハーブシャンプーAbout the Hair Shampoo Hair shampoos include those that are developed to address particular hair issues like split ends, dry hair, and frizzy hair. The need for healthy, lustrous, and well-groomed hair influences the purchasing decision of most consumers. In 2014, Herbal Essence launched its Herbal Essences Naked Volume Collection, which consists of shampoo, conditioner, dry shampoo, leave-in cond …
- がん診断の世界市場分析：タイプ別（臨床検査、遺伝検査、画像検査、内視鏡検査）、用途別（乳房、肺、肝臓、子宮頸、結腸直腸、皮膚）、地域別、セグメント予測、2014 – 2025The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced la …
- FX Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013FX Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary FX Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
- 世界のVoLTE市場：機会、課題、戦略、予測VoLTE (Voice over LTE) technology allows a voice call to be placed over an LTE network, enabling operators to reduce reliance on legacy circuit-switched networks. Powered by IMS (IP Multimedia Subsystem) architecture, VoLTE brings a host of benefits to mobile operators ranging from the ability to refarm legacy 2G and 3G spectrum to offering their subscribers a differentiated service experience thr …
- 世界の再保険（Reinsurance）市場動向（2014～2018）TechNavio's analysts forecast the Global Reinsurance market to grow at a CAGR of 3.13 percent over the period 2013-2018. One of the key factors contributing to this market growth is the robust growth of the global economy. The Global Reinsurance market has also been witnessing the growth in urbanization across the globe. However, the delayed implementation of Solvency II regulations is delaying gr …
- 世界のデジタルゲーム（ビデオゲーム）市場（2014-2018）About Digital Game Market Video games are electronic games that include a video device for human interaction with the user interface of the game. The video device might be a mobile display, PC monitor, or TV. The electronic systems used to play video games are known as platforms. The different types of platforms are TVs, consoles, mobile devices, PCs, and others. There are various types of games a …
- ICT予算及び人員配置動向：製薬産業部門- 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? Kable’s survey shows that overall ICT spending in the pharmaceutical sector is set to increase in 2013 compared to 2012, with the highest proportion of the average ICT budget being allocated to hardware, followed …
- ジェネリック医薬品の世界市場予測2016-2026What can be expected from the Generic Drugs Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects. Our 306-page report provides 175 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecast …
- 商用海藻類の世界市場：紅藻類、褐藻類、緑藻類The commercial seaweeds market is projected to grow at a CAGR of 9.17% to reachUSD 17.59 Billion by 2021. The market growth is driven by increasing awareness about the pharmaceutical uses of seaweeds and growing demand from the European region. The market is further driven by factors such as growing awareness of nutritive values in seaweeds and their thickening and gelling properties which can be …
- 産業用UPS（無停電電源装置）のグローバル市場（2014-2018）About Industrial UPS A UPS system is an electrical appliance used to provide power backup to a load during a power breakdown. These UPS systems provide instantaneous power backup by ensuring continuous power supply from energy stored in batteries. UPS systems are widely deployed for continuous power supply in various industries such as the Data Center and IT, Chemical, and Food Processing industri …
